Pharming Group N.V. (PHGUF)
USD 0.9
(0.0%)
USD 0.9
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.02 USD | -176.67% |
| 2022 | 0.02 USD | -16.0% |
| 2021 | 0.02 EUR | -56.9% |
| 2020 | 0.06 EUR | -10.36% |
| 2019 | 0.06 EUR | 37.37% |
| 2018 | 0.05 EUR | 126.17% |
| 2017 | -0.18 EUR | -305.41% |
| 2016 | -0.04 EUR | -66.92% |
| 2015 | -0.03 EUR | -50.28% |
| 2014 | -0.02 EUR | 81.73% |
| 2013 | -0.10 EUR | 77.47% |
| 2012 | -0.43 EUR | 8.51% |
| 2011 | -0.47 EUR | 81.12% |
| 2010 | -2.49 EUR | 0.0% |
| 2009 | - USD | 100.0% |
| 2008 | -3.95 EUR | -14.83% |
| 2007 | -3.44 EUR | 0.0% |
| 2006 | - USD | 100.0% |
| 2005 | -2.65 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | -0.00 USD | -11.11% |
| 2024 Q2 | -0.00 USD | 90.22% |
| 2024 Q1 | -0.02 USD | -348.78% |
| 2023 FY | - USD | -176.67% |
| 2023 Q4 | -0.00 USD | -178.85% |
| 2023 Q1 | -0.02 USD | 6.4% |
| 2023 Q2 | 0.00 USD | 110.53% |
| 2023 Q3 | 0.01 USD | 160.0% |
| 2022 Q1 | 0.01 USD | 56.25% |
| 2022 Q2 | 0.02 USD | 324.0% |
| 2022 Q3 | 0.01 USD | -36.32% |
| 2022 Q4 | -0.02 USD | -250.37% |
| 2022 FY | - USD | -16.0% |
| 2021 Q3 | -0.00 EUR | -106.74% |
| 2021 Q2 | 0.01 EUR | -31.54% |
| 2021 Q1 | 0.01 EUR | 28.71% |
| 2021 Q4 | 0.00 EUR | 633.33% |
| 2021 FY | - EUR | -56.9% |
| 2020 FY | - EUR | -10.36% |
| 2020 Q4 | 0.01 EUR | -26.28% |
| 2020 Q1 | 0.01 EUR | -33.18% |
| 2020 Q2 | 0.02 EUR | 23.08% |
| 2020 Q3 | 0.01 EUR | -22.16% |
| 2019 Q2 | 0.01 EUR | -0.81% |
| 2019 FY | - EUR | 37.37% |
| 2019 Q4 | 0.02 EUR | 18.23% |
| 2019 Q3 | 0.02 EUR | 47.15% |
| 2019 Q1 | 0.01 EUR | -53.03% |
| 2018 Q4 | 0.03 EUR | 172.16% |
| 2018 Q2 | 0.01 EUR | -46.85% |
| 2018 FY | - EUR | 126.17% |
| 2018 Q3 | 0.01 EUR | 64.41% |
| 2018 Q1 | 0.01 EUR | 111.44% |
| 2017 Q2 | -0.06 EUR | -369.53% |
| 2017 Q1 | -0.01 EUR | 22.42% |
| 2017 Q3 | -0.02 EUR | 68.72% |
| 2017 FY | - EUR | -305.41% |
| 2017 Q4 | -0.10 EUR | -415.96% |
| 2016 Q1 | -0.01 EUR | 20.87% |
| 2016 FY | - EUR | -66.92% |
| 2016 Q4 | -0.02 EUR | -60.19% |
| 2016 Q3 | -0.01 EUR | -18.39% |
| 2016 Q2 | -0.01 EUR | 4.4% |
| 2015 Q1 | -0.00 EUR | -106.9% |
| 2015 FY | - EUR | -50.28% |
| 2015 Q4 | -0.01 EUR | -105.36% |
| 2015 Q3 | -0.01 EUR | 24.32% |
| 2015 Q2 | -0.01 EUR | -131.25% |
| 2014 Q3 | -0.00 EUR | 77.86% |
| 2014 Q4 | 0.05 EUR | 1596.77% |
| 2014 FY | - EUR | 81.73% |
| 2014 Q1 | -0.06 EUR | -226.82% |
| 2014 Q2 | -0.01 EUR | 76.07% |
| 2013 Q3 | -0.02 EUR | -86.47% |
| 2013 Q4 | -0.02 EUR | 27.82% |
| 2013 FY | - EUR | 77.47% |
| 2013 Q1 | -0.06 EUR | -616.05% |
| 2013 Q2 | -0.01 EUR | 77.07% |
| 2012 Q2 | -0.19 EUR | -18.13% |
| 2012 Q3 | -0.13 EUR | 31.22% |
| 2012 FY | - EUR | 8.51% |
| 2012 Q4 | -0.01 EUR | 93.77% |
| 2012 Q1 | -0.16 EUR | -81.82% |
| 2011 Q2 | -0.14 EUR | -29.09% |
| 2011 Q1 | -0.11 EUR | 83.15% |
| 2011 Q3 | -0.15 EUR | -2.82% |
| 2011 Q4 | -0.09 EUR | 39.73% |
| 2011 FY | - EUR | 81.12% |
| 2010 Q4 | -0.65 EUR | -151.15% |
| 2010 Q3 | -0.26 EUR | 75.21% |
| 2010 Q2 | -1.05 EUR | 0.0% |
| 2010 FY | - EUR | 0.0% |
| 2010 Q1 | - USD | 100.0% |
| 2009 FY | - USD | 100.0% |
| 2009 Q4 | -0.71 EUR | 30.59% |
| 2009 Q3 | -1.02 EUR | 15.42% |
| 2009 Q1 | -0.83 EUR | 0.0% |
| 2009 Q2 | -1.21 EUR | -45.3% |
| 2008 FY | - EUR | -14.83% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - USD | 100.0% |
| 2005 FY | - EUR | 0.0% |